Skip to search.
 TSX Up 0.17% TSX Ventures Up 1.33%

aTyr Pharma, Inc. (LIFE)

-NasdaqGS
3.05 Down 0.05(1.61%) Dec 2, 4:00PM EST
Prev Close:3.10
Open:3.10
Bid:2.95 x 200
Ask:3.80 x 100
1y Target Est:6.67
Beta:1.41
Next Earnings Date:N/A
Day's Range:2.90 - 3.10
52wk Range:2.48 - 10.93
Volume:82,369
Avg Vol (3m):124,614
Market Cap:72.34M
P/E (ttm):N/A
EPS (ttm):-2.61
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-2.54
Quarterly EPS Est (Dec-16) :-0.63
Mean Recommendation*:2.8
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and clinical development of Physiocrine-based therapeutics for patients suffering from severe and rare diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback